KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Invested Capital (2018 - 2025)

Amneal Pharmaceuticals has reported Return on Invested Capital over the past 8 years, most recently at 0.15% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.15% for Q4 2025, down 15.0% from a year ago — trailing twelve months through Dec 2025 was 0.15% (down 15.0% YoY), and the annual figure for FY2025 was 0.3%, up 2.0%.
  • Return on Invested Capital for Q4 2025 was 0.15% at Amneal Pharmaceuticals, up from 0.13% in the prior quarter.
  • Over the last five years, Return on Invested Capital for AMRX hit a ceiling of 0.3% in Q4 2024 and a floor of 0.09% in Q2 2022.
  • Median Return on Invested Capital over the past 5 years was 0.09% (2023), compared with a mean of 0.08%.
  • Biggest five-year swings in Return on Invested Capital: soared 111bps in 2021 and later decreased -27bps in 2022.
  • Amneal Pharmaceuticals' Return on Invested Capital stood at 0.23% in 2021, then tumbled by -115bps to 0.03% in 2022, then surged by 377bps to 0.1% in 2023, then surged by 211bps to 0.3% in 2024, then crashed by -51bps to 0.15% in 2025.
  • The last three reported values for Return on Invested Capital were 0.15% (Q4 2025), 0.13% (Q3 2025), and 0.1% (Q2 2025) per Business Quant data.